FastBreak Medical is developing an innovative, disposable patch for real-time stroke detection.
Current Status
FastBreak Medical has made significant progress, including a successful POC clinical study, completion of patch design, and the granting of U.S. Patent No. 11,385,518. We’ve received positive feedback from key opinion leaders, established a European Consortium, and applied for a $3M Horizon Pathfinder Open grant. We were also selected for collaborations with the University of Michigan entrepreneurship program and the Merage 45+ program. Recently, we secured $150,000 in matching funds from the Israel Innovation Authority.
Problem or Opportunity
Prehospital delay due to late detection is the main barrier to receive effective therapy following an ischemic event. FastBreak Medical develops a disposable non invasice patch device for real time detection of ischemic stroke thereby reducing treatment delay and improve patient’s outcome.
Solution (product or service)
The solution involves a patch device placed on both sides of the neck above the carotid arteries to continuously monitor blood pressure changes. When a brain artery is suddenly blocked, it creates an acute increase in blood pressure upstream in the carotid artery on the affected side, while the other side remains unchanged. This generates an asymmetry in the blood pressure patterns between the right and left carotid arteries, which is not seen in healthy individuals. By using Artificial Intelligence (AI), these asymmetries can be analyzed to detect stroke events.
Business model
FastBreak’s business model targets three markets: EMS, hospitals, and home use. In EMS, revenue comes from $5,000 software units and $100 disposable patch sets, with a U.S. market potential of $0.5 billion. Hospitals rely on $100 patch sets for stroke monitoring, addressing a $1.5 billion market. The home market focuses on high-risk atrial fibrillation patients through a subscription model with a $300 initial fee and $50 monthly charges, plus $150 monthly reimbursements, generating $4.8 billion annually. The strategy emphasizes scalable, user-friendly solutions and strong reimbursement pathway